Global Pharmaceutical Biotech Market Report

The pharmaceutical biotechnology market comprises development, manufacturing and marketing of products manufactured on the basis of advanced biotechnology research. Pharmaceutical biotechnology industry focuses on biotech concepts of recombinant proteins, monoclonal antibodies, gene therapy and transgenic organism among others.

In 2008, the global biotech market grew by 8.8% and had a market value of $216.3 billion. The medical/healthcare was the most lucrative segment for the global pharmaceutical biotechnology market in 2008 that generated 69% of the biotech market´s overall revenues. Americas account for 57.9% of the total biotech market´s revenue and thus leads the global biotechnology market. As far as future predictions for biotech market are concerned, it is forecast to reach a value of $305.7 billion in 2013, an increase of 41.3% since 2008.

Read the Pharmaceutical Biotechnology Industry Report 2009-2010

Indian Pharmaceuticals Industry 2010 Report

According to a special report, published by Fitch Ratings, the Indian Pharmaceutical Sector will remain stable in 2010, with demand benefiting from rising global acceptance of generic pharmaceuticals. The agency also expects the credit profiles of some of its rated entities to remain stable - a result of limited capex spends and subsequent improvement in cash flows.

The global pharmaceutical industry is facing a period of significant drug patent expiries, which expands the addressable market for generics companies. Regulatory steps taken by developed countries towards curtailing growing health care budgets can also boost the demand for generics. The agency expects the global acceptance of generics along with outsourcing of manufacturing by global pharmaceutical companies to low cost locations will benefit the export oriented Indian pharmaceutical companies. Steady demand growth will continue to give advantage to the domestic pharmaceutical companies of India. However, Fitch Ratings stated that pricing pressures because of greater-than-expected increase in competition could moderate the anticipated profitability improvements. This would remain a key risk factor for future margins. Regulatory issues can also have an impact, mainly regarding approvals for new products and any rigidity in quality controls.

The report further states that a majority of the entities within its rated national pharmaceutical portfolio are not likely to see any large future capacity expansions. They will focus on consolidating their recently expanded capex in the next couple of years. Nonetheless Fitch views any large debt-led capex programme with concern.

With the global liquidity scenario improving in 2010, Indian pharmaceutical exporters should see shorter cash cycles for their working capital, versus the increase in working capital cycles during the tight liquidity situation in 2008-H109. Liquidity is thus expected to generally remain comfortable. The improved liquidity scenario coupled with improved cash flows in the near term should partly offset the refinancing risks faced from foreign currency convertible bonds outstanding on the books of many Indian pharmaceutical companies.

News Source- Press release from Fitch Ratings based on their special report, 'Indian Pharma Outlook 2010'

Read More Pharmaceutical News

Pharmaceutical Industry Trends

As in any other business, pharmaceutical industry too needs to know the key market forecasts & growth opportunities in the near future. Many researches are conducted for the purpose of presenting a detailed trend analysis of the global pharmaceutical market almost every year. These reports help pharmaceutical companies in major decision making issues. The global pharmaceutical market is forecast to grow exceeding $825 billion in 2010, an equivalent CAGR of about 6%. The global pharmaceutical market sales is expected to grow at a 4 - 7% compound annual growth rate (CAGR) and its value is expected to expand to $975+ billion by 2013. Different regions of the world will influence the pharmaceutical industry trends in different ways. Read Pharmaceutical Market Trends 2010 for detailed report on region specific and drugs specific growth of pharma market.

Side Effects of Diabetes Medicine

Diabetes or more popularly known as blood sugar is a disease when your body fails to regulate blood sugar level because of the disturbance in the level of insulin production. Diabetes are of three types:

1. Type 1
2. Type 2
3. Gestational Diabetes

In type 1 diabetes less insulin is made by the body whereas in type 2 diabetes the body becomes resistant to insulin. Gestational diabetes occurs only in female and happen at the time of pregnancy. The reason behind gestational diabetes is unknown. Heart disease, kidney disease, nerve damage, eye problem and foot problem are other associated effects of diabetes if it is not controlled on time.

There are many anti-diabetic drugs that are prescribed by the doctors to the patient for controlling the diabetes or blood sugar.

Side Effects of Diabetes Medicine

Metformin hydrochloride
This is also called Glucophage XR and the most commonly used diabetes medicine. The regular use of this medicine can lead to kidney problems. So if you have a kidney problem then your doctor must know this before prescribing the medicine for diabetes. Larger quantities of Metformin hydrochloride diabetes medicine can also lead to extended diarrhea. People taking metformin may face the problem of weakness, tiredness, and trouble in breathing. If these problem persists then call your doctor for immediate assistance.

Insulin
Insulin is injected directly in the blood to immediately control the blood sugar level. It can either be given  through injections or through insulin pumps. But excess of this can lead to weight gain as the sugar is directly given to the blood cells. 

Sulfonylureas
It is the first oral hypoglycemic medication that comes under the brand name of  Amaryl, DiaBeta, Diabinese, Dymelor, Glucotrol, Glucotrol XL, Glynase PresTab, Micronase, Orinase, Tolinase.  Patients taking this diabetes medicine can show side effects of hypoglycemia, an upset stomach and weight gain. Some can even develop skin rash or itching.

Byetta
Byetta, a subcutaneous injection is a very recent development in the field of diabetes medicines. If you have taken the meal and very close to the meal you have taken Byetta then you may suffer from stomach pain and nausea. On the other hand it can also lead to constipation. Another thing that makes it less favourable is its non functionality after one or two years of the use.

Thiazolidinediones
Generic name: pioglitazone, rosiglitazone
Your liver enzyme level must be checked regularly if you are taking this diabetes medicine. If you develop any sign such as stomach pain, vomiting, nausea, yellowing of skin or whites of eyes, dark yellow colored urine then you must call your doctor. Weight gain, liver problem and risk of developing anemia are other problems associated with the use of Thiazolidinediones.

Glucotrol
This diabetes medicine is also called glipizide and has least side effects. At the extreme end patient can suffer from headaches.

Lantus Long Acting Insulin
Just the weight gain is the problem associated with this diabetes medicine.